Nok Therapeutics, Inc.
Amendment
CIK: 0002038166·Biotechnology·FLORIDA·Filed: May 1, 2026
Total Offering
Indefinite
Amount Sold
$750,500
Investors
5
First Sale
Sep 24, 2024
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2024
- Non-Accredited Investors
- Yes
Related Persons
| Name | Role |
|---|---|
| Robert Lewis | |
| Brian Cogley | |
| Bruce Cassidy | |
| Martin Lewis | |
| Michael Lewis | |
| David Mehalick |
Company
SEC Filing
0001213900-26-050994
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free